APA (7th ed.) Citation

Zhang, L., Wu, D., Li, L., Zhao, Q., Yang, H., Han, X., . . . Gao, L. Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: A randomized controlled trial. BMC.

Chicago Style (17th ed.) Citation

Zhang, Lidan, Di Wu, Liang Li, Qin Zhao, Hailing Yang, Xiaoyong Han, Liang Liu, and Lu Gao. Rivaroxaban Versus Low Molecular Weight Heparin for Managing Lower Extremity Deep Vein Thrombosis Following Thoracoscopic Lung Cancer Surgery: A Randomized Controlled Trial. BMC.

MLA (9th ed.) Citation

Zhang, Lidan, et al. Rivaroxaban Versus Low Molecular Weight Heparin for Managing Lower Extremity Deep Vein Thrombosis Following Thoracoscopic Lung Cancer Surgery: A Randomized Controlled Trial. BMC.